in , , ,

Fogarty International Center Advisory Board Meets 7 Feb

NIH Fogarty International Center

The National Institutes of Health (NIH) Fogarty International Center Advisory Board will host a meeting on February 7, 2017 in Washington D.C. to discuss current and planned Center activities.

​The Center facilitates global health research conducted by U.S. and international investigators, builds partnerships between health research institutions in the U.S. and abroad, and trains the next generation of scientists to address global health needs.  Fogarty currently funds some 400 research and training projects involving more than 100 U.S. universities.

The Advisory Board is comprised of researchers, policymakers and others involved in global health. Members meet three times each year to provide second-level review of Fogarty grant applications. They also provide strategic advice to the Center on its policies, programs and other matters.

Portions of the meeting will be closed to the public, to protect discussions which could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications.

The open portion of the meeting will occur from 9:00 am to 3:00 pm ET at National Institutes of Health, Stone House, Building 16, Conference Room, Bethesda, MD.

A full agenda for the meeting is available here.

Any interested person may file written comments with the committee by forwarding the statement to Kristen Weymouth, Executive Secretary, Fogarty International Center, National Institutes of Health, 31 Center Drive, Room B2C02, Bethesda, MD 20892, (301) 496-1415, The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Sources: Federal Register, NIH FIC website

Global Biosurveillance Networks

DHS Seeks to Improve Analytics for Prediction of Bio-Threat Incidents

Crimean Congo Hemorrhagic Fever Vaccine

International Partners Work to Develop Crimean–Congo Hemorrhagic Fever Vaccine